PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 24 No. 4
Pages: 1  2  
Next
 

The Religion of Benzodiazepines

By Cynthia M. A. Geppert, MD, PhD | April 1, 2007
Dr Geppert is chief of behavioral care consultation and medical director of the substance abuse residential rehabilitation treatment program at the New Mexico Veterans Affairs Health Care System in Albuquerque. She is also assistant professor in the department of psychiatry and associate director of religious studies at the University of New Mexico in Albuquerque.

Man is tormented by no greater anxiety than to find someone quickly to whom he can hand over that great gift of freedom with which the ill-fated creature is born.
—Fyodor Dostoevsky, The Brothers Karamazov

Several months ago, a new psychiatrist came from a prestigious university in the Northeast to work in the VA hospital out West where I practice. During one of our initial conversations, he expressed the emphatic view that "benzodiazepines are only useful for acute alcohol(Drug information on alcohol) withdrawal or psychiatric emergencies and other than that they have no place in pharmacology." I juxtaposed this position with that of several of our older clinicians, who are equally strong advocates of the generous use of benzodiazepines for a variety of psychiatric symptoms.

I mentioned this marked difference of opinion among our service to a wise mentor who responded, "benzodiazepines are a religion and this new fellow is an atheist while the others are true believers." While I am sure he meant the statement somewhat ironically, it started me thinking about the subject of science and faith in pharmacology and how this particular class of medications arouses passionate, even sectarian, divisions reminiscent of religious debates. This was not an entirely novel line of thought for me, since I can recall as a resident being struck by the wide and intense spectrum of theory and protocol among the attendings regarding benzodiazepines, especially for patients with a history of substance abuse. I once drew the diagram below to illustrate the polemic and have since employed it with my own residents to illustrate the divergence of faculty perspectives (Figure).

The science of benzodiazepines is not nearly as controversial as the faith.I was fortunate enough to have trained under Dr E. H. Uhlenhuth, one of the world's foremost experts on benzodiazepines. In a series of rigorous reviews and elegant clinical studies,1-3 he has defended these much-maligned medications, as in the following abstract:

"Despite a sharp decline in the prescription of benzodiazepines during the past decade, reservations about their use have continued to escalate. . . . Data from . . . diverse sources . . . suggest that (1) the risks of overuse, dependence, and addiction with benzodiazepines are low in relation to the massive exposure in our society; (2) benzodiazepine addiction can occur when doses within the clinical range are taken regularly over about 6 months; (3) many patients continue to derive benefit from long-term treatment with benzodiazepines; and (4) attitudes strongly against the use of these drugs may be depriving many anxious patients of appropriate treatment."4

The last statement of this passage returns to our theme that it is more likely that provider perspectives, rather than cold clinical facts, underlie the immense light and heat surrounding these agents. In an excellent review of the history of attitudes toward benzodiazepines, Rosenbaum5 points out that despite the beneficial aspects of these nearly 4-decade-old drugs, there have been persistent concerns that benzodiazepines were being overprescribed and abused and that the risks of physical dependence and withdrawal were being underplayed. In contrast, proponents of the agents have argued that these objections diminish and dismiss the suffering and severity of anxiety disorders and insomnia.

In an essay in 1972, Klerman6 had characterized these 2 opposing perspectives toward the use of medications that relieve distress with the quasi-theological or moral terms, "pharmacological Calvinism" and "psychotropic hedonism." Kramer,7 in the best-selling Listening to Prozac, revisited this contrast with reference to the mood-brightening properties of fluoxetine(Drug information on fluoxetine). In a footnote in this book, Kramer mentions that, "In the 1980s Klerman told me he wished he had instead used the phrase 'pharmacological puritanism,' as more expressive of the judgmental and prohibitive quality of the objection to medication." For readers for whom it has been a few years since they took a philosophy or religion class, I would like to briefly review the historical schools of puritanism and hedonism to see what, in fact, they have to say about this contemporary issue in modern psychiatry.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by richard wallace | July 14, 2011 10:28 AM EDT

I HAVE BEEN TREATING PATIENTS FOR 49 YRS I HAVE NOT SEEN ANYONE GET ANY BETTER BY TAKING BENZOS FOR ANY LONGER TIME THEN 1 MONTH.

I DO NOT START MY PATIENTS ON XANAX EVER. I ALWAYS GET THEM AFTER THEY HAVE BEEN DEPENDANT ON IT FOR YRS.

IT IS THE ONLY MED THAT I GET MORE STORIES ABOUT WHY A PATIENT NEEDS A REFILL, NEVER ANY OTHER PSYCH MED.

I SING A SONG TO MY PATIENTS ONCE IN LOVE WITH ZANAX ALWAYS IN LOVE WITH XANAX.


CIGS, OXY,AND XANAX GREAT MONEYMAKERS FOR THOSE SELLING THEM.

DR. WALLACE I STILL SEE PATIENTS FULL TIME AND LOVE IT.

by Gary Mallit | June 27, 2011 12:43 PM EDT

Judging a medication as good or bad sets one up for tunnel vision and thus we prescribe out of our comfort rather than patient need. What happens when we do not look at each patient individually causes undo suffering. Patients may benefit from these medicines for anxiety of course but if we fail to look at the etiology and just say no then we may do more harm than good. Chronic Pain can cause anxiety and benzodiazepines may reduce opiate need and prevent acute flares. While this one of many examples, I think like most medications that can be good or bad benzodiazepines get a bad rap. When a patient has an anaphylactic reaction to an antibiotic should we have predicted it just as should we predict benzodiazepines will be abused. While a good history helps with these decisions sometimes we must just try a medication when warranted and follow closely for adverse effects.

Gary Mallit

by John Janes | May 05, 2011 9:26 PM EDT

Things have changed since 2007. Death by combining benzodiazepines with opiates and other drugs appears to be increasing, at least in some areas: http://www.statesman.com/news/local/prescription-meds-killing-more-than-illegal-street-drugs-1447275.html

The article states, "Among the cases they reviewed - the deaths spanned across age and ethnic groups - Xanax and Valium were among the most common drugs victims took."

Maybe not so benign after all.

by Wayne MacKenzie | April 06, 2011 7:58 PM EDT

I dare say that while there is a responsibility on the part of the clinician to "do no harm"the ontological debate on what constitutes greater harm will forever rage. A recurring memory imparted by an elder has stuck in my head like a buzzing gnat whenever I contemplate the necessity to renew a benzo prescription. The gnat keeps buzzing "never met a person who gained insight from a pill"

by sudhakar bhat | April 01, 2011 6:26 PM EDT

Perhaps the problem is our tendency to prescribe and once the patient's pain is dulled, forget the cause of the pain- our failure to use modes of treatment other than drugs once benzodiazepines show their benefit.

Dr T.Sudhakar Bhat

Article Comment Pages: 1 2 3 Previous Next







 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • An Update on ADHD
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Ethical and Legal Issues in Geriatric Psychiatry
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy